Dr. David Urech
Venture Partner at BioMedPartners
About
A biotech entrepreneur and antibody engineer best known as co-founder and former CEO of Numab Therapeutics, which he built into a clinical-stage leader in multi-specific antibody therapeutics. He also co-founded Yellow Jersey Therapeutics whose lead asset was acquired by Johnson & Johnson in 2024 for approximately $1.25 billion.
Colleagues at BioMedPartners
Aristotelis
Managing Partner at BioMedPartners
Aristotelis Nastos
Managing Partner at BioMedPartners
Claudia Ulbrich
Venture Partner at BioMedPartners
David Urech
Venture Partner at BioMedPartners
Dr. Aristotelis Nastos
Managing Partner at BioMedPartners
Dr. Claudia Ulbrich
Venture Partner at BioMedPartners
Dr. Marianna Feretzaki
Senior Associate at BioMedPartners
Dr. Markus Hosang
Managing Partner at BioMedPartners